Terms: = Skin cancer AND DNMT3A, Q9Y6K1, 1788, ENSG00000119772, DNMT3A2, M_HsaIIIA
49 results:
1. Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort.
Gurnari C; Pascale MR; Vitale A; Diral E; Tomelleri A; Galossi E; Falconi G; Bruno A; Crisafulli F; Frassi M; Cattaneo C; Bertoli D; Bernardi M; Condorelli A; Morsia E; Poloni A; Crisà E; Caravelli D; Triggianese P; Brussino L; Battipaglia G; Bindoli S; Sfriso P; Caroni F; Dragani M; Mallegni F; Pilo F; Firinu D; Curti A; Papayannidis C; Olivieri A; Kordasti S; Albano F; Pane F; Musto P; Bocchia M; Lugli E; Breccia M; Frigeni M; Dagna L; Greco R; Franceschini F; Campochiaro C; Cantarini L; Voso MT
Am J Hematol; 2024 Feb; 99(2):254-262. PubMed ID: 38108611
[TBL] [Abstract] [Full Text] [Related]
2. Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow.
Sadigh S; DeAngelo DJ; Garcia JS; Hasserjian RP; Hergott CB; Lane AA; Lovitch SB; Lucas F; Luskin MR; Morgan EA; Pinkus GS; Pozdnyakova O; Rodig SJ; Shanmugam V; Tsai HK; Winer ES; Zemmour D; Kim AS
Mod Pathol; 2024 Jan; 37(1):100352. PubMed ID: 37839675
[TBL] [Abstract] [Full Text] [Related]
3. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].
Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766
[No Abstract] [Full Text] [Related]
4. Melanoma in a patient with dnmt3a overgrowth syndrome.
Chen DY; Sutton LA; Ramakrishnan SM; Duncavage EJ; Heath SE; Compton LA; Miller CA; Ley TJ
Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 37160317
[TBL] [Abstract] [Full Text] [Related]
5. Common and rare variant associations with clonal haematopoiesis phenotypes.
Kessler MD; Damask A; O'Keeffe S; Banerjee N; Li D; Watanabe K; Marketta A; Van Meter M; Semrau S; Horowitz J; Tang J; Kosmicki JA; Rajagopal VM; Zou Y; Houvras Y; Ghosh A; Gillies C; Mbatchou J; White RR; Verweij N; Bovijn J; Parikshak NN; LeBlanc MG; Jones M; ; ; Glass DJ; Lotta LA; Cantor MN; Atwal GS; Locke AE; Ferreira MAR; Deering R; Paulding C; Shuldiner AR; Thurston G; Ferrando AA; Salerno W; Reid JG; Overton JD; Marchini J; Kang HM; Baras A; Abecasis GR; Jorgenson E
Nature; 2022 Dec; 612(7939):301-309. PubMed ID: 36450978
[TBL] [Abstract] [Full Text] [Related]
6. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
Wang L; Rocas D; Dalle S; Sako N; Pelletier L; Martin N; Dupuy A; Tazi N; Balme B; Vergier B; Beylot-Barry M; Carlotti A; Bagot M; Battistella M; Chaby G; Ingen-Housz-Oro S; Gaulard P; Ortonne N
Br J Dermatol; 2022 Dec; 187(6):970-980. PubMed ID: 35895386
[TBL] [Abstract] [Full Text] [Related]
7. skin Aging in Long-Lived Naked Mole-Rats Is Accompanied by Increased Expression of Longevity-Associated and Tumor Suppressor Genes.
Fatima I; Chen G; Botchkareva NV; Sharov AA; Thornton D; Wilkinson HN; Hardman MJ; Grutzkau A; Pedro de Magalhaes J; Seluanov A; Smith ESJ; Gorbunova V; Mardaryev AN; Faulkes CG; Botchkarev VA
J Invest Dermatol; 2022 Nov; 142(11):2853-2863.e4. PubMed ID: 35691364
[TBL] [Abstract] [Full Text] [Related]
8. Inhibiting the growth of melanoma cells via hTERT gene editing using CRISPR-dCas9-dnmt3a system.
Rad FT; Gargari BN; Ghorbian S; Farsani ZS; Sharifi R
Gene; 2022 Jun; 828():146477. PubMed ID: 35398175
[TBL] [Abstract] [Full Text] [Related]
9. Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML.
Yang F; Long N; Anekpuritanang T; Bottomly D; Savage JC; Lee T; Solis-Ruiz J; Borate U; Wilmot B; Tognon C; Bock AM; Pollyea DA; Radhakrishnan S; Radhakrishnan S; Patel P; Collins RH; Tantravahi S; Deininger MW; Fan G; Druker B; Shinde U; Tyner JW; Press RD; McWeeney S; Agarwal A
Blood; 2022 Feb; 139(8):1208-1221. PubMed ID: 34482403
[TBL] [Abstract] [Full Text] [Related]
10. TET2 and dnmt3a mutations and exceptional response to 4'-thio-2'-deoxycytidine in human solid tumor models.
Yang SX; Hollingshead M; Rubinstein L; Nguyen D; Larenjeira ABA; Kinders RJ; Difilippantonio M; Doroshow JH
J Hematol Oncol; 2021 May; 14(1):83. PubMed ID: 34039392
[TBL] [Abstract] [Full Text] [Related]
11. dnmt3a deficiency in the skin causes focal, canonical DNA hypomethylation and a cellular proliferation phenotype.
Chen DY; Ferguson IM; Braun KA; Sutton LA; Helton NM; Ramakrishnan SM; Smith AM; Miller CA; Ley TJ
Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33846253
[TBL] [Abstract] [Full Text] [Related]
12. Epigenetic Changes in Neoplastic Mast Cells and Potential Impact in Mastocytosis.
Reszka E; Jabłońska E; Wieczorek E; Valent P; Arock M; Nilsson G; Nedoszytko B; Niedoszytko M
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803981
[TBL] [Abstract] [Full Text] [Related]
13. Chronic Immune-Related Adverse Events Following Adjuvant Anti-PD-1 Therapy for High-risk Resected Melanoma.
Patrinely JR; Johnson R; Lawless AR; Bhave P; Sawyers A; Dimitrova M; Yeoh HL; Palmeri M; Ye F; Fan R; Davis EJ; Rapisuwon S; Long GV; Haydon A; Osman I; Mehnert JM; Carlino MS; Sullivan RJ; Menzies AM; Johnson DB
JAMA Oncol; 2021 May; 7(5):744-748. PubMed ID: 33764387
[TBL] [Abstract] [Full Text] [Related]
14. Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders: A Clinical, Pathologic, and Molecular Study of 60 Cases Presenting With a Single Lesion: A Multicenter Study of the French Cutaneous Lymphoma Study Group.
Beltzung F; Ortonne N; Pelletier L; Beylot-Barry M; Ingen-Housz-Oro S; Franck F; Pereira B; Godfraind C; Delfau MH; D'Incan M; Vergier B
Am J Surg Pathol; 2020 Jul; 44(7):862-872. PubMed ID: 32271188
[TBL] [Abstract] [Full Text] [Related]
15. Epigenetic modifiers dnmt3a and BCOR are recurrently mutated in CYLD cutaneous syndrome.
Davies HR; Hodgson K; Schwalbe E; Coxhead J; Sinclair N; Zou X; Cockell S; Husain A; Nik-Zainal S; Rajan N
Nat Commun; 2019 Oct; 10(1):4717. PubMed ID: 31624251
[TBL] [Abstract] [Full Text] [Related]
16. ALPK1 hotspot mutation as a driver of human spiradenoma and spiradenocarcinoma.
Rashid M; van der Horst M; Mentzel T; Butera F; Ferreira I; Pance A; Rütten A; Luzar B; Marusic Z; de Saint Aubain N; Ko JS; Billings SD; Chen S; Abi Daoud M; Hewinson J; Louzada S; Harms PW; Cerretelli G; Robles-Espinoza CD; Patel RM; van der Weyden L; Bakal C; Hornick JL; Arends MJ; Brenn T; Adams DJ
Nat Commun; 2019 May; 10(1):2213. PubMed ID: 31101826
[TBL] [Abstract] [Full Text] [Related]
17. DNMT1 and DNMT3B genetic polymorphisms affect the clinical course and outcome of melanoma patients.
Maric H; Supic G; Kandolf-Sekulovic L; Maric V; Mijuskovic Z; Radevic T; Rajovic M; Magic Z
Melanoma Res; 2019 Dec; 29(6):596-602. PubMed ID: 30950914
[TBL] [Abstract] [Full Text] [Related]
18. [New molecular pathological strategies for malignant iris tumors].
Kakkassery V; Jünemann AM; Scheef BO; Grisanti S; Heindl LM
Ophthalmologe; 2019 Apr; 116(4):324-331. PubMed ID: 30623224
[TBL] [Abstract] [Full Text] [Related]
19. Consumer Acceptance and Expectations of a Mobile Health Application to Photograph skin Lesions for Early Detection of Melanoma.
Koh U; Horsham C; Soyer HP; Loescher LJ; Gillespie N; Vagenas D; Janda M
Dermatology; 2019; 235(1):4-10. PubMed ID: 30404081
[TBL] [Abstract] [Full Text] [Related]
20. SUV39H1/dnmt3a-dependent methylation of the RB1 promoter stimulates PIN1 expression and melanoma development.
Kim G; Kim JY; Lim SC; Lee KY; Kim O; Choi HS
FASEB J; 2018 Oct; 32(10):5647-5660. PubMed ID: 29750576
[TBL] [Abstract] [Full Text] [Related]
[Next]
